Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05223920
Title Extension Study of Bomedemstat (IMG-7289) in Patients With Myeloproliferative Neoplasms
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Imago BioSciences,Inc.
Age Groups: senior | adult
Covered Countries USA | ITA | GBR | DEU | AUS

Facility Status City State Zip Country Details
University of Miami Leonard M. Miller Miami Florida 33136 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
Cleveland Clinic Foundation Cleveland Ohio 44195 United States Details
UMPC Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
Fred Hutchinson Cancer Center Seattle Washington 98109 United States Details
Royal Prince Alfred Hospital Camperdown New South Wales 2050 Australia Details
Royal North Shore Hospital Saint Leonards New South Wales 2065 Australia Details
Gold Coast Hospital and Health Service Southport Queensland 4215 Australia Details
Royal Adelaide Hospital Adelaide South Australia 5000 Australia Details
Universittsklinikum Essen Essen 45147 Germany Details
Queen Mary Hospital Hong Kong Hong Kong Details
Ospedale di Circolo-a Fondazione Macchi Varese VA 2100 Italy Details
Azienda Ospedaliera SS. Antonio Alessandria 15121 Italy Details
Azienda Ospedaliero-Universitaria Careggi - S.O.D. Ematologia (CRIMM) Firenze 50134 Italy Details
Azienda Ospedaliero Universitaria di Bologna Pavia 27100 Italy Details
Middlemore Clinical Trials Papatoetoe Aukland 2025 New Zealand Details
Waitemata District Health Board Takapuna Aukland 0622 New Zealand Details
University College London Hospitals NHS Foundation Trust London NW1 12G United Kingdom Details
Guy's and Saint Thomas' NHS Foundation Trus London SE1 9RT United Kingdom Details
*Shaded cells indicate that there was no data available from for the field